Ex parte ALLEN - Page 10




                   Appeal No. 1996-0826                                                                                                                               
                   Application No. 08/271,583                                                                                                                         


                   claims on appeal "read on" something disclosed in the reference.  Kalman v. Kimberly-Clark Corp.,                                                  

                   713 F.2d 760, 772, 218 USPQ 781, 789 (Fed. Cir. 1983), cert. denied, 465 U.S. 1026 (1984).                                                         

                             Claims 1, 5, 14, 15, 19 and 28 are rejected under 35 U.S.C. § 102 as anticipated by Nedwin.                                              

                             Nedwin discloses a method for killing target cells, e.g., cancer cells, bacteria, fungi, yeast,                                          

                   protozoa, viruses and other parasites, having a characteristic surface antigen in a subject having such                                            

                   cells, comprising administering in vivo, ex vivo or in vitro a composition comprising an effective                                                 

                   amount of a peroxidase, preferably myeloperoxidase, conjugated to a first binding agent capable of                                                 

                   specifically binding to the surface antigen, preferably an antibody (i.e., a myeloperoxidase derivative)7                                          

                   and a sufficient amount of a hydrogen peroxide-producing enzyme system conjugated to a second                                                      

                   binding agent (which may be identical to the first binding agent) capable of specifically binding to a                                             

                   surface antigen (page 3, lines 10-21 and 49-54).  In the presence of hydrogen peroxide, the peroxidase                                             

                   converts local halide ions, particularly iodide and chloride, into cytotoxic halide species (page 4, lines                                         

                   28-29).  The specific binding conjugates “provide an very fast, specific killing action” (page 7, line 6).                                         

                   Selective killing, e.g., cytotoxicity against myeloma cancer cells and lack of toxicity to non-target cells,                                       

                   is demonstrated in the examples on page 8.  The antibody-targeted specific killing action of target cells                                          




                             7According to the specification, “[i]llustrative examples of useful derivatives include haloperoxidases which                            
                   have been conjugated to antibodies, antibody fragments, lectins or other targeting moieties which are capable of                                   
                   specifically recognizing and selectively binding to antigens, receptor sites, or other distinguishing features on the                              
                   surface of target microbes or target cells, such as cancer cells” (page 15, lines 31-36).                                                          
                                                                               - 10 -                                                                                 





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  Next 

Last modified: November 3, 2007